<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>PR Hub &#187; CryoLife</title>
	<atom:link href="http://blog.taragana.com/pr/t/cryolife/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.taragana.com/pr</link>
	<description></description>
	<pubDate>Thu, 01 Oct 2009 15:13:21 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Leading Cardiovascular Surgeons Gather from Around the World to Share Ross Procedure Survival Data, Techniques at 2nd Annual Summit</title>
		<link>http://blog.taragana.com/pr/leading-cardiovascular-surgeons-gather-from-around-the-world-to-share-ross-procedure-survival-data-techniques-at-2nd-annual-summit-6312/</link>
		<comments>http://blog.taragana.com/pr/leading-cardiovascular-surgeons-gather-from-around-the-world-to-share-ross-procedure-survival-data-techniques-at-2nd-annual-summit-6312/#comments</comments>
		<pubDate>Mon, 21 Sep 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Atlanta]]></category>

		<category><![CDATA[CryoLife]]></category>

		<category><![CDATA[georgia]]></category>

		<category><![CDATA[Inc.]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/leading-cardiovascular-surgeons-gather-from-around-the-world-to-share-ross-procedure-survival-data-techniques-at-2nd-annual-summit-6312/</guid>
		<description><![CDATA[ATLANTA - 
- Growing Outcomes Evidence Spurs Renewed Interest in Unique Heart Valve Procedure

CryoLife, Inc. (NYSE: CRY) &#8212; Elite cardiovascular surgeons from around the world will travel to suburban Atlanta this week for the two-day Ross Summit to review and discuss current peer-reviewed data relating to the survival advantage of the Ross Procedure and to [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/leading-cardiovascular-surgeons-gather-from-around-the-world-to-share-ross-procedure-survival-data-techniques-at-2nd-annual-summit-6312/feed/</wfw:commentRss>
		</item>
		<item>
		<title>CryoLife&#8217;s Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World</title>
		<link>http://blog.taragana.com/pr/cryolifes-second-annual-surgical-congress-for-the-ross-procedure-to-draw-more-than-130-cardiovascular-surgeons-from-around-the-world-5499/</link>
		<comments>http://blog.taragana.com/pr/cryolifes-second-annual-surgical-congress-for-the-ross-procedure-to-draw-more-than-130-cardiovascular-surgeons-from-around-the-world-5499/#comments</comments>
		<pubDate>Thu, 03 Sep 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Trade Show]]></category>

		<category><![CDATA[Atlanta]]></category>

		<category><![CDATA[CryoLife]]></category>

		<category><![CDATA[georgia]]></category>

		<category><![CDATA[Inc.]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/cryolifes-second-annual-surgical-congress-for-the-ross-procedure-to-draw-more-than-130-cardiovascular-surgeons-from-around-the-world-5499/</guid>
		<description><![CDATA[ATLANTA - 
- The Ross Summit 2009 to focus on new patient data supporting the Ross heart reconstruction procedure and the use of SynerGraft(R) processed human heart valves in the Ross Procedure

More than 130 cardiovascular surgeons from approximately 30 countries are scheduled to attend the second annual global Ross Summit, a two-day surgical congress focused [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/cryolifes-second-annual-surgical-congress-for-the-ross-procedure-to-draw-more-than-130-cardiovascular-surgeons-from-around-the-world-5499/feed/</wfw:commentRss>
		</item>
		<item>
		<title>CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology</title>
		<link>http://blog.taragana.com/pr/cryolife-receives-ce-mark-approval-for-biofoamr-hemostatic-technology-4650/</link>
		<comments>http://blog.taragana.com/pr/cryolife-receives-ce-mark-approval-for-biofoamr-hemostatic-technology-4650/#comments</comments>
		<pubDate>Tue, 04 Aug 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Atlanta]]></category>

		<category><![CDATA[CryoLife]]></category>

		<category><![CDATA[georgia]]></category>

		<category><![CDATA[Inc.]]></category>

		<category><![CDATA[President]]></category>

		<category><![CDATA[Scandinavia]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/cryolife-receives-ce-mark-approval-for-biofoamr-hemostatic-technology-4650/</guid>
		<description><![CDATA[ATLANTA - 
CryoLife, Inc., (NYSE: CRY) an implantable biological medical device and cardiovascular tissue processing company, today announced it has received CE mark approval for its BioFoam(R) Surgical Matrix (BioFoam). The CE mark allows immediate, unrestricted commercial distribution of BioFoam in the European Community for use as an adjunct in the sealing of abdominal parenchymal [...]]]></description>
		<wfw:commentRss>http://blog.taragana.com/pr/cryolife-receives-ce-mark-approval-for-biofoamr-hemostatic-technology-4650/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

